T1	Participants 551 692	76 centres in the Czech Republic, Germany, Hungary, India, Poland, Russia, Ukraine, Turkey, and the UK between Feb 15, 2008, and May 14, 2010
T2	Participants 694 763	Patients aged 18-55 years with relapsing-remitting multiple sclerosis
